Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

AstraZeneca AZN0.05%increase; green up pointing triangle said it plans to pump $2 billion in new investment into the U.S., ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid ...

AstraZeneca's China president Leon Wang, who was detained last month by Chinese authorities, is in touch with a lawyer but ...

Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions of dollars into properties in the United ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

AstraZeneca Pharma tumbled 5.12% to Rs 6,768 after the pharmaceutical firm's net profit declined 26.62% to Rs 38.43 crore in Q2 FY25 as compared with Rs 52.37 crore posted in Q2 FY24.

Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...

AstraZeneca raised its full-year guidance after third-quarter results topped analysts’ expectations, boosted by its cancer ...

AstraZeneca Pharma India reported its financial results for Q2 FY25, showing a notable revenue increase. Revenue from ...

英国剑桥 - AstraZeneca PLC (LSE/STO/Nasdaq: AZN) 宣布在美国进行重大扩张，投资35亿美元用于扩大其研究和制造能力。这项投资计划将在2026年底前完成，预计将创造超过一千个高技能就业岗位，为经济增长做出贡献。 这家生物制药公司的投资将包括在马萨诸塞州剑桥市肯德尔广场建立一个新的最先进的研发中心，以及在马里兰州建立一个下一代生物制品制造设施。其他发展还包括在美国 ...